Russell Investments Group Ltd. grew its position in Lantheus Holdings Inc (NASDAQ:LNTH) by 14.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 321,681 shares of the medical equipment provider’s stock after acquiring an additional 41,028 shares during the period. Russell Investments Group Ltd. owned about 0.86% of Lantheus worth $5,726,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently made changes to their positions in LNTH. California Public Employees Retirement System grew its position in shares of Lantheus by 29.2% in the 1st quarter. California Public Employees Retirement System now owns 77,800 shares of the medical equipment provider’s stock valued at $973,000 after acquiring an additional 17,600 shares during the period. Vanguard Group Inc. boosted its holdings in shares of Lantheus by 7.0% during the 1st quarter. Vanguard Group Inc. now owns 788,396 shares of the medical equipment provider’s stock worth $9,855,000 after buying an additional 51,590 shares during the period. Dimensional Fund Advisors LP bought a new stake in shares of Lantheus during the 1st quarter worth about $3,646,000. Capstone Asset Management Co. bought a new stake in shares of Lantheus during the 2nd quarter worth about $286,000. Finally, State of Alaska Department of Revenue bought a new stake in shares of Lantheus during the 2nd quarter worth about $102,000. 91.91% of the stock is owned by institutional investors.
Several brokerages recently commented on LNTH. Zacks Investment Research raised shares of Lantheus from a “hold” rating to a “strong-buy” rating and set a $26.00 target price for the company in a report on Tuesday, November 7th. Jefferies Group lifted their target price on shares of Lantheus from $22.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 3rd. Credit Suisse Group lifted their target price on shares of Lantheus from $19.00 to $23.00 and gave the stock a “neutral” rating in a report on Friday, November 3rd. BidaskClub raised shares of Lantheus from a “hold” rating to a “buy” rating in a report on Wednesday, December 27th. Finally, ValuEngine downgraded shares of Lantheus from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $24.50.
Lantheus Holdings Inc (NASDAQ LNTH) traded up $0.55 during midday trading on Tuesday, reaching $21.00. 257,727 shares of the company’s stock were exchanged, compared to its average volume of 317,100. The company has a quick ratio of 2.46, a current ratio of 2.96 and a debt-to-equity ratio of -3.41. The company has a market cap of $787.63 and a P/E ratio of 26.25. Lantheus Holdings Inc has a 52-week low of $7.95 and a 52-week high of $24.10.
Lantheus (NASDAQ:LNTH) last posted its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported $0.24 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.20 by $0.04. The firm had revenue of $79.94 million during the quarter, compared to the consensus estimate of $77.18 million. Lantheus had a net margin of 9.59% and a negative return on equity of 46.45%. The business’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.15 EPS. research analysts forecast that Lantheus Holdings Inc will post 1.05 earnings per share for the current fiscal year.
In other news, SVP Timothy G. Healey sold 11,314 shares of the business’s stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $21.51, for a total value of $243,364.14. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Michael P. Duffy sold 11,917 shares of the business’s stock in a transaction that occurred on Tuesday, November 14th. The shares were sold at an average price of $21.63, for a total transaction of $257,764.71. Following the completion of the transaction, the insider now owns 152,301 shares of the company’s stock, valued at $3,294,270.63. The disclosure for this sale can be found here. Insiders sold a total of 29,986 shares of company stock valued at $625,488 in the last three months. Insiders own 2.30% of the company’s stock.
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.